New Water-Soluble Boswellia Extract Broadens Joint-Health Applications
The new AquaLox ingredient from PLT Health Solutions is a water-soluble version of the company’s 5-Loxin joint-health ingredient.
Photo © iStockphoto.com/HansJoachim
Despite the popularity of Boswellia serrata extract in joint-health products, its lack of water-solubility and unpleasant taste has made it a challenging ingredient to work with in certain applications. But AquaLox, a new water-soluble Boswellia extract from PLT Health Solutions (Morristown, NJ), may allow for a much broader range of applications for the popular ayurvedic spice.
AquaLox is a water-soluble version of PLT’s established 5-Loxin ingredient, which has been studied for its beneficial effects on joint comfort and protection against cartilage degradation. PLT Health Solutions says the new ingredient has “a similar pharmacokinetic profile to 5-Loxin.”
In addition to its water-solubility, AquaLOX also marks a “major breakthrough” because of its pleasant taste profile, which PLT Solutions says now allows for the Boswellia serrata extract to be used in taste-sensitive delivery systems like gummies, chews, stick-packs, and shots for the first time.
“5-Loxin is a market-leading joint-health ingredient, available in well over a hundred consumer products on the market today,” says Seth Flowerman, executive vice president, PLT Health Solutions. “In a market that demands convenience and novel delivery systems, all Boswellia extracts were limited because of the challenging taste profile and lack of solubility-and the technology needed to achieve this was tricky. With AquaLOX, we are finally able to deliver on our customers’ wish list and extend the 5-Loxin franchise to a whole new range of products.”
Read more:
PLT Health Solutions Launches Trust-Building Initiative
More Evidence that Lecithin Delivery System Boosts Boswellia Bioavailability
MSM and Boswellic Acids Comparable to Glucosamine for Osteoarthritis Relief, Study Says
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
